Merck KGaA, Remepy team up on software-enhanced hybrid drugs for rare tumors

April 28, 2026

More like this

Remepy to Collaborate with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas

American Pharmaceutical Review

Merck partners Remepy in PDURS-focused alliance

Pharmaphorum

Merck KGaA and Remepy join forces to develop combo drug-digital therapies

Pharmaceutical Technology